145 related articles for article (PubMed ID: 34532121)
1. The expression and prognostic value of REXO4 in hepatocellular carcinoma.
Chen W; Gao C; Shen J; Yao L; Liang X; Chen Z
J Gastrointest Oncol; 2021 Aug; 12(4):1704-1717. PubMed ID: 34532121
[TBL] [Abstract][Full Text] [Related]
2.
Ruan Y; Chen W; Gao C; Xu Y; Shi M; Zhou Z; Zhou G
J Gastrointest Oncol; 2021 Dec; 12(6):3093-3106. PubMed ID: 35070432
[TBL] [Abstract][Full Text] [Related]
3. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
4. CLEC3B as a potential diagnostic and prognostic biomarker in lung cancer and association with the immune microenvironment.
Sun J; Xie T; Jamal M; Tu Z; Li X; Wu Y; Li J; Zhang Q; Huang X
Cancer Cell Int; 2020; 20():106. PubMed ID: 32265595
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
[TBL] [Abstract][Full Text] [Related]
6. ALDH2 is a prognostic biomarker and related with immune infiltrates in HCC.
Yao S; Yin X; Chen T; Chen W; Zuo H; Bi Z; Zhang X; Jing Y; Pang L; Cheng H
Am J Cancer Res; 2021; 11(11):5319-5337. PubMed ID: 34873463
[TBL] [Abstract][Full Text] [Related]
7. Prognostic implication of NQO1 overexpression in hepatocellular carcinoma.
Lin L; Sun J; Tan Y; Li Z; Kong F; Shen Y; Liu C; Chen L
Hum Pathol; 2017 Nov; 69():31-37. PubMed ID: 28964792
[TBL] [Abstract][Full Text] [Related]
8. Low expression of AQP9 and its value in hepatocellular carcinoma.
Gao C; Shen J; Yao L; Xia Z; Liang X; Zhu R; Chen Z
Transl Cancer Res; 2021 Apr; 10(4):1826-1841. PubMed ID: 35116505
[TBL] [Abstract][Full Text] [Related]
9. Exploring the Prognostic Value, Immune Implication and Biological Function of
Huang Y; Huang S; Ma L; Wang Y; Wang X; Xiao L; Qin W; Li L; Yuan X
Front Immunol; 2021; 12():723293. PubMed ID: 34899687
[TBL] [Abstract][Full Text] [Related]
10. Xanthine dehydrogenase as a prognostic biomarker related to tumor immunology in hepatocellular carcinoma.
Lin Z; Xie YZ; Zhao MC; Hou PP; Tang J; Chen GL
Cancer Cell Int; 2021 Sep; 21(1):475. PubMed ID: 34496841
[TBL] [Abstract][Full Text] [Related]
11. Expression, immune infiltration and clinical significance of SPAG5 in hepatocellular carcinoma: A gene expression-based study.
Chen W; Chen X; Li S; Ren B
J Gene Med; 2020 Apr; 22(4):e3155. PubMed ID: 31860771
[TBL] [Abstract][Full Text] [Related]
12. EOGT Correlated With Immune Infiltration: A Candidate Prognostic Biomarker for Hepatocellular Carcinoma.
Shu Y; He L; Gao M; Xiao F; Yang J; Wang S; Wei H; Zhang F; Wei H
Front Immunol; 2021; 12():780509. PubMed ID: 35069551
[TBL] [Abstract][Full Text] [Related]
13. Prognostic biomarker SMARCC1 and its association with immune infiltrates in hepatocellular carcinoma.
Cai X; Zhou J; Deng J; Chen Z
Cancer Cell Int; 2021 Dec; 21(1):701. PubMed ID: 34937564
[TBL] [Abstract][Full Text] [Related]
14. Correlation of zinc finger protein 2, a prognostic biomarker, with immune infiltrates in liver cancer.
Sun L; Lin Y; Wang G; Zhang L; Hu L; Lu Z
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33439969
[TBL] [Abstract][Full Text] [Related]
15. Increased
Gao C; Shen J; Chen W; Yao L; Liang X; Zhu R; Chen Z
J Gastrointest Oncol; 2021 Aug; 12(4):1905-1926. PubMed ID: 34532138
[TBL] [Abstract][Full Text] [Related]
16. Highly expressed centromere protein L indicates adverse survival and associates with immune infiltration in hepatocellular carcinoma.
Zeng Z; Jiang X; Pan Z; Zhou R; Lin Z; Tang Y; Cui Y; Zhang E; Cao Z
Aging (Albany NY); 2021 Oct; 13(19):22802-22829. PubMed ID: 34607313
[TBL] [Abstract][Full Text] [Related]
17. A Comprehensive Prognostic Analysis of POLD1 in Hepatocellular Carcinoma.
Tang H; You T; Sun Z; Bai C
BMC Cancer; 2022 Feb; 22(1):197. PubMed ID: 35189839
[TBL] [Abstract][Full Text] [Related]
18. Identification of CDC20 as an immune infiltration-correlated prognostic biomarker in hepatocellular carcinoma.
Xiong C; Wang Z; Wang G; Zhang C; Jin S; Jiang G; Bai D
Invest New Drugs; 2021 Oct; 39(5):1439-1453. PubMed ID: 33942202
[TBL] [Abstract][Full Text] [Related]
19. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
20. CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma.
Su J; Huang Y; Wang Y; Li R; Deng W; Zhang H; Xiong H
Cancer Cell Int; 2022 Feb; 22(1):67. PubMed ID: 35139863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]